author-photo

Martin Pflügler

German Cancer Research Center

4

Papers

10

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma.

2020 BMJ Open
Show All
- Source
- Cite
- Save
Citations (2)